Tuberculosis

Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya +4 more·2016·Nature Reviews Disease Primers

Cited by (1,000)

Items 501–600 of 1,000

  1. Synthesis of Long‐Chain β‐Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria
    Pierre Santucci, Christina Dedaki, Alexandros Athanasoulis, Laura Gallorini, Anaïs Munoz, Stéphane Canaan, Jean‐François Cavalier, Victoria Magrioti · 2019 · ChemMedChem
  2. Locally-secreted interleukin-6 is related with radiological severity in smear-negative pulmonary tuberculosis
    Paula Ximena Losada, Federico Perdomo-Celis, Marcela Castro, Carol Salcedo, Arnold Salcedo, Isabel F. DeLaura, Giovani Lastra, Carlos Fernando Narváez · 2019 · Cytokine
  3. Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer
    Davide M. Ferraris, Edoardo Luigi Maria Gelardi, Silvia Garavaglia, Riccardo Miggiano, Menico Rizzi · 2020 · Biochemical Society Transactions
  4. CCR5 Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population
    Shuyuan Liu, Nannan Liu, Hui Wang, Xinwen Zhang, Yufeng Yao, Shuqiong Zhang, Li Shi · 2021 · Frontiers in Immunology
  5. Structure-Based Virtual Screening of Benzaldehyde Thiosemicarbazone Derivatives against DNA Gyrase B of Mycobacterium tuberculosis
    A. Kistan, Balakrishnan Anna Benedict, Sundaramoorthy Vasanthan, Alphonse PremKumar, Malathi Kullappan, Jenifer Mallavarpu Ambrose, Vishnu Priya Veeraraghavan, Gayathri Rengasamy, Krishna Mohan Surapaneni · 2021 · Evidence-based Complementary and Alternative Medicine
  6. The Medicinal Chemistry of Chalcones as Anti-Mycobacterium tuberculosis Agents
    Jean Leandro dos Santos, Cristhian N. Rodríguez-Silva, Igor Muccilo Prokopczyk · 2022 · Mini-Reviews in Medicinal Chemistry
  7. Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives
    Vasiliki Mavrikaki, Alexandros Pagonis, Isabelle Poncin, Ivy Mallick, Stéphane Canaan, Victoria Magrioti, Jean‐François Cavalier · 2022 · Bioorganic & Medicinal Chemistry Letters
  8. Mycobacterium tuberculosis-specific memory T cells in bronchoalveolar lavage of patients with pulmonary tuberculosis
    ­Jun Li­, Qiusheng Jing, Zhimin Hu, Xuan Wang, Yan Hu, Jing Zhang, Li Li · 2023 · Cytokine
  9. Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers
    Stefan H. E. Kaufmann, January Mikolaj Weiner, Jeroen Maertzdorf · 2017 · Expert Review of Vaccines
  10. Infectious Agents and Bone Marrow Failure: A Causal or a Casual Connection?
    Valentina Giudice, Antonio Maria Risitano, Carmine Selleri · 2021 · Frontiers in Medicine
  11. Aryl-n-hexanamide linked enaminones of usnic acid as promising antimicrobial agents
    Pavan Kumar Bangalore, Ravi Kumar Pedapati, Naga Pranathi Abburi, Uma Rajeswari Batchu, Sunil Misra, Madhurekha Estharala, Dharmarajan Sriram, Srinivas Kantevari · 2022 · Molecular Diversity
  12. Neue Impfstoffe gegen Tuberkulose
    Stefan H. E. Kaufmann · 2019 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  13. Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis
    Tola, Habteyes Hailu, Holakouie-Naieni, Kourosh, Lejisa, Tadesse, Mansournia, Mohammad Ali, Yaseri, Mehdi, Tesfaye, Ephrem, Mola, Million · 2019 · PLoS ONE
  14. Polymorphisms in ERAP1 and ERAP2 Genes Are Associated With Tuberculosis in the Han Chinese
    Shuqiong Zhang, Shuyuan Liu, Nannan Liu, Chuanyin Li, Hui Wang, Lei Shi, Xinwen Zhang, Ling Bao, Yufeng Yao, Li Shi · 2020 · Frontiers in Genetics
  15. Impact of Latent Tuberculosis on Diabetes
    Burcu Tepekule, Katharina Kusejko, Marius Zeeb, PHILIP E. TARR, Alexandra Calmy, Manuel Battegay, Hansjakob Furrer, Matthias L. Cavassini, Enos Bernasconi, Julia Notter et al. · 2022 · The Journal of Infectious Diseases
  16. Comparison of the Immunogenic Properties of Lactiplantibacillus plantarum Carrying the Mycobacterial Ag85B-ESAT-6 Antigen at Various Cellular Localizations
    Kamilla Wiull, Preben Boysen, Katarzyna Kuczkowska, Lars Fredrik Moen, Harald Carlsen, Vincent G. H. Eijsink, Geir Mathiesen · 2022 · Frontiers in Microbiology
  17. A five-antigen Esx-5a fusion delivered as a prime-boost regimen protects against M.tb challenge
    Elena Stylianou, Nawamin Pinpathomrat, Oliver L. Sampson, Alexandre Richard, Marcellus, Helen McShane · 2023 · Frontiers in Immunology
  18. Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis
    Camila Maríngolo Ribeiro, Cesar Augusto Roque‐Borda, Maria Carolina Franzini, Karyn Fernanda Manieri, Fernanda Manaia Demarqui, Debora Leite Campos, Rachel Temperani Amaral Machado, Isabel Cristiane da Silva, Marcela Tavares Luiz, Leonardo Delello Di Filippo et al. · 2024 · International Journal of Pharmaceutics
  19. Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis
    Bo‐Hao Tang, Xin-Fang Zhang, Shu‐Meng Fu, Bu‐Fan Yao, Wei Zhang, Yue‐E Wu, Yi Zheng, Yue Zhou, John N. van den Anker, Hairong Huang et al. · 2024 · Clinical Pharmacokinetics
  20. Identification of small molecular ligands as potent inhibitors of fatty acid metabolism in Mycobacterium tuberculosis
    Ramesh Malikanti, Rajender Vadija, Hymavathi Veeravarapu, Kiran Kumar Mustyala, Vasavi Malkhed, Uma Vuruputuri · 2017 · Journal of Molecular Structure
  21. Tuberculous Myelopathy Associated with Longitudinally Extensive Lesion: A Clinicoradiological Review of Reported Cases
    Mohamad Syafeeq Faeez Md Noh, Norafida Binti Bahari, Anna Misyail Abdul Rashid · 2020 · Journal of Clinical Neurology
  22. An Army Marches on Its Stomach: Metabolic Intermediates as Antimicrobial Mediators in Mycobacterium tuberculosis Infection
    Emer E. Hackett, Frederick J. Sheedy · 2020 · Frontiers in Cellular and Infection Microbiology
  23. Fusion of Dendritic Cells Activating Rv2299c Protein Enhances the Protective Immunity of Ag85B-ESAT6 Vaccine Candidate against Tuberculosis
    Yong Woo Back, Hyun Shik Bae, Han‐Gyu Choi, Dang Thi Binh, Yeo‐Jin Son, Seunga Choi, Hwa‐Jung Kim · 2020 · Pathogens
  24. Language impairments and CNS infections: a review
    Adrià Rofes, Diederik van de Beek, Gabriele Miceli · 2021 · Aphasiology
  25. “If I’ve got latent TB, I would like to get rid of it”: Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment
    Ruvandhi R. Nathavitharana, Ananja van der Westhuizen, Helene‐Mari van der Westhuizen, Hridesh Kumar Mishra, Annalean Sampson, Jack Meintjes, Edward Anthony Nardell, Andrew McDowell, Grant Theron · 2021 · PLoS ONE
  26. The impact of single-cell genomics on the field of mycobacterial infection
    Inês Geraldes, Mónica Fernandes, Alexandra G. Fraga, Nuno Sampaio Osório · 2022 · Frontiers in Microbiology
  27. Screening for tuberculosis infection in children and adolescents by two intracutaneous tests: with tuberculin and tuberculosis recombinant allergen (ESAT-6/CFP-10) in Moscow in 2021
    Elena M. Bogorodskaya, L. V. Slogotskaya, L. F. Shamuratova, T. A. Sevostyanova · 2022 · Tuberculosis and lung diseases
  28. Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 counts
    Maphe Mthembu, Kathryn A. Bowman, Leela R. L. Davies, Sharon Khuzwayo, Lusanda Mazibuko, Thierry Bassett, Dirhona Ramjit, Zoey Mhlane, Farina Karim, Galit Alter et al. · 2023 · EBioMedicine
  29. A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar
    Christine Pando, Ashley Hazel, Lai Yu Tsang, Kimmerling Razafindrina, Andry Andriamiadanarivo, Roger Mario Rabetombosoa, Ideal Ambinintsoa, Gouri B. Sadananda, Peter M. Small, Astrid M. Knoblauch et al. · 2023 · BMC Public Health
  30. Antibodies as clinical tools for tuberculosis
    Sophie McIntyre, Jeffrey M. Warner, C. M. Rush, Hillary A. Vanderven · 2023 · Frontiers in Immunology
  31. Synchronization of Mycobacterium life cycle: A possible novel mechanism of antimycobacterial drug resistance evolution and its manipulation
    Hritika Verma, Aditi Chauhan, Awanish Kumar, Manoj Kumar, Kajal Kanchan · 2024 · Life Sciences
  32. Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase
    Christopher M. Goins, Celine M. Schreidah, Steven Dajnowicz, Donald R. Ronning · 2017 · Journal of Biological Chemistry
  33. Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries
    Lena Faust, Anne E. McCarthy, Yoko Schreiber · 2018 · BMC Public Health
  34. Latent tuberculosis in migrants travelling through the northeast regions of Mexico
    Obed Medina-Macías, Philippe Stoesslé, Leonardo E. Perales-Rendón, Jorge Eugenio Moreno-Cuevas, Francisco González‐Salazar · 2020 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
  35. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors
    Thales Kronenberger, Gláucio Monteiro Ferreira, Alfredo Danilo Ferreira de Souza, Soraya da Silva Santos, Antti Poso, João Augusto Ribeiro, Maurício T. Tavares, Fernando Rogerio Pavan, Gustavo Henrique Goulart Trossini, M.V.B. Dias et al. · 2020 · Bioorganic & Medicinal Chemistry
  36. In-host population dynamics of M. tuberculosis during treatment failure
    Roger Vargas, Luca Freschi, Maximillian G. Marin, L. Elaine Epperson, Melissa Laird Smith, Irina A. Oussenko, David Durbin, Michael Strong, Max Salfinger, Maha Reda Farhat · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Impact of Reversion of Mycobacterium tuberculosis Immunoreactivity Tests on the Estimated Annual Risk of Tuberculosis Infection
    Alvaro Schwalb, Jon C. Emery, Katie Dale, Katherine Chisholm Horton, César Ugarte‐Gil, Rein M G J Houben · 2023 · American Journal of Epidemiology
  38. Synthesis, antitubercular profile and molecular docking studies of quinazolinone-based pyridine derivatives against drug-resistant tuberculosis
    Madihalli Srinivas Raghu, Kumarswamy Yogesh Kumar, T. Shamala, Fahad A. Alharti, M.K. Prashanth, Byong‐Hun Jeon · 2023 · Journal of Biomolecular Structure and Dynamics
  39. Infection and the Glycome─New Insights into Host Response
    F. Ifthiha Mohideen, Lara K. Mahal · 2024 · ACS Infectious Diseases
  40. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents
    Xinyu Peng, Ziqian Zeng, Said Hassan, Yongbo Xue · 2024 · Bioorganic Chemistry
  41. Advancing Roles and Therapeutic Potentials of Pyroptosis in Host Immune Defenses against Tuberculosis
    Jiayi Yang, Yuhe Ma, Jiaqi Yu, Yilin Liu, Jiaojiao Xia, Xinen Kong, Xiaoying Jin, Jiaxiang Li, Siqi Lin, Yongdui Ruan et al. · 2024 · Biomolecules
  42. Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells
    Ali Hazrati, Seyed Mohamad Javad Mirarefin, Kosar Malekpour, Arezou Rahimi, Arezou Khosrojerdi, Ashkan Rasouli, S. Akrami, Sara Soudi · 2024 · Frontiers in Immunology
  43. Functional and mechanistic insights into the stealth protein full-length CpsY is conducive to understanding immune evasion mechanisms by Mycobacterium tuberculosis
    Dafeng Liu, Ablikim Abdiriyim, Lvxia Zhang, Buayxam Ruzitohti · 2025 · Tuberculosis
  44. Modeling Tuberculosis Dynamics with Awareness and Vaccination Using Laplace-Adomian and Fractional Calculus
    Morufu Oyedunsi Olayiwola, Ezekiel Abiodun Oluwafemi · 2025 · Iranian Journal of Science
  45. Tertiary Lymphoid Structures in Tuberculosis: Persistence, Protection, and Pathology
    Tiphaine M N Camarasa, Lorenzo Iseppi, D. Schreiner, C. King · 2025 · Immunological Reviews
  46. Autologous human iPSC–derived alveolus-on-chip reveals early pathological events of Mycobacterium tuberculosis infection
    Chak Hon Luk, Gabriel L. Conway, Kim Jee Goh, Antony Fearns, Irene Rodríguez Hernández, Nathan J. Day, Natalia Athanasiadi, Rocco D’Antuono, Enrica Pellegrino, Janick D. Stucki et al. · 2026 · Science Advances
  47. Latent tuberculosis infection prevalence in rural Madagascar
    Gouri B. Sadananda, Astrid M. Knoblauch, Andry Andriamiadanarivo, Kimmerling Razafindrina, Ideal Ambinintsoa, Roger Mario Rabetombosoa, Christine Pando, Lai Yu Tsang, Peter M. Small, Niaina Rakotosamimanana et al. · 2020 · Transactions of the Royal Society of Tropical Medicine and Hygiene
  48. Immune status changing helps diagnose osteoarticular tuberculosis
    Tuo Liang, Jiarui Chen, Guoyong Xu, Zide Zhang, Jiang Xue, Haopeng Zeng, Jie Jiang, Tianyou Chen, Zhaojie Qin, Hao Li et al. · 2021 · PLoS ONE
  49. Fluorescent Semiconductor Nanorods for the Solid-Phase Polymerase Chain Reaction-Based, Multiplexed Gene Detection of Mycobacterium tuberculosis
    Salwa Ali Ibrahim, Yinthai Chan · 2021 · ACS Applied Materials & Interfaces
  50. GSK-3α/β Activity Negatively Regulates MMP-1/9 Expression to Suppress Mycobacterium tuberculosis Infection
    Xinying Zhou, Linmiao Lie, Yao Yun Liang, Hui Xu, Bo Zhu, Yingqi Huang, Lijie Zhang, Zelin Zhang, Qianna Li, Qi Wang et al. · 2022 · Frontiers in Immunology
  51. High-resolution crystal structure of LpqH, an immunomodulatory surface lipoprotein of Mycobacterium tuberculosis reveals a distinct fold and a conserved cleft on its surface.
    Shruti Chatterjee, S. Kundapura, A. J. Basak, Debangshu Mukherjee, Sagarika Dash, Namrata Ganguly, A. Das, Gayatri Mukherjee, D. Samanta, U. Ramagopal · 2022 · International Journal of Biological Macromolecules
  52. Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents
    Maha Q. M. Qahtan, Etify Abdel-Ghafar Bakhite, Jyothi Kumari, Ahmed Mahmoud Mohammed Sayed, Mahmoud K Kandeel, Dharmarajan Sriram, Hajjaj H.M. Abdu-Allah · 2023 · Bioorganic Chemistry
  53. Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series
    Peiling Zhang, Liang Huang, Miao Zheng, Chao Zhang, Dongyi Wan, Jia Wei, Yang Cao · 2023 · Frontiers in Cellular and Infection Microbiology
  54. Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse
    Srikantiah Chandrashekara, Renuka Panchagnula, Yogitha Chennupati · 2023 · Lara D. Veeken
  55. New heterocyclic compounds from Ranunculus ternatus Thunb.
    Zi‐Ming Feng, Zhi-Lai Zhan, Ya‐Nan Yang, Jian‐Shuang Jiang, Pei‐Cheng Zhang · 2017 · Bioorganic Chemistry
  56. Estimating the impact of tuberculosis anatomical classification on treatment outcomes: A patient and surveillance perspective analysis
    Otavio Ranzani, Laura Cunha Rodrigues, Eliseu Alves Waldman, Carlos Roberto Ribeiro de Carvalho · 2017 · PLoS ONE
  57. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children
    Sylvia M. LaCourse, Barbra A. Richardson, John Kinuthia, Alex Jay Warr, Elizabeth Maleche‐Obimbo, Daniel N. Matemo, Lisa Marie Cranmer, Jaclyn N Escudero, Thomas R. Hawn, Grace C. John-Stewart · 2020 · BMJ Open
  58. Multicenter Evaluation of Xpert MTB/RIF Ultra Tests Reporting Detection of “Trace” of Mycobacterium tuberculosis DNA
    Ester Mazzola, Paola Dal Monte, Claudio Piersimoni, Annalisa Del Giudice, Anna Camaggi, Cristina Pedrotti, Francesca Gurrieri, Cristina Russo, Claudio Farina, Alessandra Vernaglia Lombardi et al. · 2021 · International Journal of Mycobacteriology
  59. Advances in host‐based screening for compounds with intracellular anti‐mycobacterial activity
    Neeraja Subhash, Varadharajan Sundaramurthy · 2021 · Cellular Microbiology
  60. Emergent Pneumonia in Children
    Cecilia Perret P., Nicole Le Corre, José Antonio Castro-Rodríguez · 2021 · Frontiers in Pediatrics
  61. Microdebrider is less aerosol-generating than CO2 laser and cold instruments in microlaryngoscopy
    Enni Sanmark, Lotta‐Maria Oksanen, Noora Rantanen, Mari Lahelma, Veli‐Jukka Anttila, Nina S. Atanasova, Antti Hyvärinen, Teemu J. Kinnari, Ahmed Geneid · 2021 · European Archives of Oto-Rhino-Laryngology
  62. Tuberculosis care designed with barramarrany (family): Participatory action research that prioritised partnership, healthy housing and nutrition
    Sue Devlin, Wayne Ross, Richard Widders, Gregory McAvoy, Kirsty Browne, Kerryn Lawrence, David J. MacLaren, Peter Massey, Jenni A. Judd · 2021 · Health Promotion Journal of Australia
  63. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Mycobacterium tuberculosis and Evaluation of Their Potential in the Diagnosis of Tuberculosis in a Mouse Model and in Humans
    Wenping Gong, Yan Liang, Jie Wang, Yinping Liu, Yong Xue, Jie Mi, Pengchuan Li, Xiaoou Wang, Lan Wang, Xueqiong Wu · 2022 · Microbiology Spectrum
  64. Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study
    Luciana Fonseca Sobral, María B. Arriaga, Alexandra B. Souza, Mariana Araújo‐Pereira, Beatriz Barreto‐Duarte, Caio Sales, Michael S. Rocha, Aline Benjamin, Adriana S. R. Moreira, Jamile G. de Oliveira et al. · 2022 · The Lancet Regional Health - Americas
  65. Computed Tomography-Based Biomarker for Longitudinal Assessment of Disease Burden in Pulmonary Tuberculosis
    Pedro M. Gordaliza, Arrate Muñoz‐Barrutia, Laura E. Via, Sally A. Sharpe, Manuel Desco, Juan José Vaquero · 2018 · Molecular Imaging and Biology
  66. Granzyme B induced by Rv0140 antigen discriminates latently infected from active tuberculosis individuals
    Rym Ouni, Houda Gharsalli, Violette Dirix, Amani Braiek, Nadia Sendi, Afifa Jarraya, L. Douik El Gharbi, Mohamed‐Ridha Barbouche, Chaouki Benabdessalem · 2018 · Journal of Leukocyte Biology
  67. Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages
    Nargis Khan, Maziar Divangahi · 2018 · The Journal of Infectious Diseases
  68. Molecular probes for super-resolution imaging of drug dynamics
    Hongbao Fang, Mengmeng Wang, Pengfan Wei, Qian Liu, Yan Ru Su, Hong‐Ke Liu, Yuncong Chen, Zhi Guo Su, Weijiang He · 2024 · Advanced Drug Delivery Reviews
  69. Imaging of thoracic tuberculosis: pulmonary and extrapulmonary
    Nuttaya Pattamapaspong, Thanat Kanthawang, Wcg Peh, Nadia Hammami, Mouna Chelli Bouaziz, Mohamed Fethi Ladeb · 2023 · BJR|Open
  70. Risk factors for multidrug-resistant tuberculosis: a predictive model study
    Lianpeng Wu, Xiaoxiao Cai, Xiangao Jiang · 2024 · Frontiers in Medicine
  71. mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models
    Neha Agrawal, Louis S. Ates, Stefan A. Schille, Anuhar Chaturvedi, Janina Vogt, Nataša Vukovic, Charles L. Dulberger, Annette B. Vogel, Jan Diekmann, Mustafa Diken et al. · 2026 · Nature Immunology
  72. A Prospective Cohort Study on the Prevalent and Recurrent Tuberculosis Isolates Using the MIRU-VNTR Typing
    Beibei Qiu, Bilin Tao, Qiao Liu, Zhongqi Li, Huan Song, Dan Tian, Jizhou Wu, Zhuchao Wu, Mengyao Zhan, Wei Lu et al. · 2021 · Frontiers in Medicine
  73. A Bridging Centrality Plugin for GEPHI and a Case Study forMycobacterium TuberculosisH37Rv
    Getúlio M Pereira, Preetam Ghosh, Anderson Rodrigues dos Santos · 2021 · IEEE Transactions on Computational Biology and Bioinformatics
  74. Dehydroquinate Synthase Directly Binds to Streptomycin and Regulates Susceptibility of Mycobacterium bovis to Streptomycin in a Non-canonical Mode
    Wenping Wei, Junjie Qiao, Xiaofang Jiang, Luxia Cai, Xiaomin Hu, Jin He, Min Chen, Min Yang, Tao Cui · 2022 · Frontiers in Microbiology
  75. Comparison of diagnostic accuracy of QuantiFERON‐TB Gold Plus and T‐SPOT.TB in the diagnosis of active tuberculosis in febrile patients
    Lifan Zhang, Zhengrong Yang, Xinmiao Bao, Huimin Ma, Qiping Ge, Yueqiu Zhang, Qifei Cao, Mengqiu Gao, Xiaoqing Liu · 2022 · Journal of Evidence-Based Medicine
  76. Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition
    Alexander D. H. Kingdon, Asti-Rochelle Meosa John, Sarah M. Batt, Gurdyal Singh Besra · 2023 · Frontiers in Microbiology
  77. MUC5AC Genetic Variation Is Associated With Tuberculous Meningitis Cerebral Spinal Fluid Cytokine Responses and Mortality
    Michelle C. Sabo, Nguyễn Thụy Thương Thương, Xuling Chang, Edwin Ardiansyah, Trinh Thi Bich Tram, Hoang Thanh Hai, Ho D.T. Nghia, Nguyen Duc Bang, Sofiati Dian, Ahmad Rizal Ganiem et al. · 2023 · The Journal of Infectious Diseases
  78. Not business as usual: Engaging the corporate sector in India’s TB elimination efforts
    Madeline E. Carwile, Chelsie Cintron, Komal Jain, Giancarlo Buonomo, Matt Oliver, Madolyn Rose Dauphinais, Prakash Babu Narasimhan, Senbagavalli Prakash Babu, Sonali Sarkar, Lindsey Mina Locks et al. · 2023 · Global Public Health
  79. In silico virtual screening for the identification of novel inhibitors against dihydrodipicolinate reductase (DapB) of Mycobacterium tuberculosis , a key enzyme of diaminopimelate pathway
    Nupur Angrish, Neha Lalwani, Garima Khare · 2023 · Microbiology Spectrum
  80. Transcriptional signatures of Mycobacterium tuberculosis in mouse model of intraocular tuberculosis
    Sudhanshu Abhishek, Michelle B. Ryndak, Alpa Choudhary, Sumedha Sharma, Amod Gupta, Vishali Gupta, Nirbhai Singh, Suman Laal, Indu Verma · 2019 · Pathogens and Disease
  81. Structural features of HtpGMtb and HtpG-ESAT6Mtb vaccine antigens against tuberculosis: Molecular determinants of antigenic synergy and cytotoxicity modulation
    Miguel A. M. Moreira, Alessia Ruggiero, Luciana Esposito, Han‐Gyu Choi, Hwa‐Jung Kim, Rita Berisio · 2020 · International Journal of Biological Macromolecules
  82. Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan
    Tauseef Ahmad, Muhammad Ayub Jadoon, Muhammad Mumtaz Khan, Haroon Haroon, Muhammad Mumtaz Khan, Akbar Hussain, Taha Hussein Musa, Muhammad Waqar, Eyasu Ejeta, Manoochehr Karami et al. · 2020 · BMC Infectious Diseases
  83. Palladium-catalysed synthesis of arylnaphthoquinones as antiprotozoal and antimycobacterial agents
    Marc-Manuel Kalt, Wolfgang Schuehly, Robert Saf, Sandra Ochensberger, Julia Solnier, Franz Bučar, Marcel Kaiser, Armin Presser · 2020 · European Journal of Medicinal Chemistry
  84. Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
    Benjamin Schrijver, Douwe J. Dijkstra, Nicole V. Borggreven, Rina La Distia Nora, Erika Huijser, Marjan A. Versnel, P. Martin van Hagen, Simone A. Joosten, Leendert Adrianus Trouw, Willem A. Dik · 2020 · Clinical & Translational Immunology
  85. Natural products from Vitex polygama and their antimycobacterial and anti-inflammatory activity
    Cristiane Catela Martins de Jesus, Marlon Heggdorne de Araújo, Thatiana Lopes Biá Ventura Simão, Elena Lasunskaia, T. Barth, Michelle Frazão Muzitano, Shaft Corrêa Pinto · 2020 · Natural Product Research
  86. Proteome remodeling in the Mycobacterium tuberculosis PknG knockout: Molecular evidence for the role of this kinase in cell envelope biogenesis and hypoxia response
    Analia E. Lima, Alejandro Leyva, Bernardina Rivera, María Magdalena Portela, Magdalena Gil, Alessandro Cascioferro, María‐Natalia Lisa, Anne Marie Wehenkel, Marco Bellinzoni, Paulo C. Carvalho et al. · 2021 · Journal of Proteomics
  87. Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers
    Qingbo Shu, Shan Liu, Tonino Alonzi, Sylvia M. LaCourse, Dhiraj Kumar Singh, Duran Bao, Dalton C. Wamalwa, Li Jiang, Christopher J. Lyon, Grace C. John-Stewart et al. · 2022 · Theranostics
  88. The Microbiome as Part of the Contemporary View of Tuberculosis Disease
    Martín Barbosa-Amezcua, David Galeana-Cadena, Néstor Alvarado-Peña, Eugenia Silva‐Herzog · 2022 · Pathogens
  89. Pathology of Tuberculosis
    Soumaya Rammeh, Emna Romdhane · 2022 · Medical radiology
  90. Tuberculosis Diagnosis and Detection of Drug Resistance: A Comprehensive Updated Review
    Mahmoud M. Tawfick, Mona Shaban E. M. Badawy, Mohammed H. Taleb, Nagwan Galal El Menofy · 2023 · Journal of Pure and Applied Microbiology
  91. Who are the patients with tuberculosis who are diagnosed in emergency facilities? An analysis of treatment outcomes in the state of São Paulo, Brazil
    Otavio Ranzani, Laura Cunha Rodrigues, Eliseu Alves Waldman, Elena Prina, Carlos Roberto Ribeiro de Carvalho · 2018 · Jornal Brasileiro de Pneumologia
  92. Breaking down walls
    Moagi Tube Shaku, Bavesh Davandra Kana · 2018 · eLife
  93. When prevention is dangerous: perceptions of isoniazid preventive therapy in KwaZulu-Natal, South Africa
    Jody Boffa, Maria J. Mayan, S. Ndlovu, Dina Fisher, S. Staples, Reginald S. Sauve, Tyler S. Williamson · 2019 · Public Health Action
  94. Evaluation of endocranial bony changes in relation to tuberculosis in the Robert J. Terry Anatomical Skeletal Collection (Washington, DC, USA)
    Olga Spekker · 2018
  95. The Natural History of Untreated Pulmonary Tuberculosis in Adults: A Systematic Review and Meta-Analysis
    Bianca Sossen, Alexandra S Richards, Torben Heinsohn, Beatrice Frascella, Federica Balzarini, Aurea Oradini‐Alacreu, Anna Odone, Ewelina Rogozińska, Brit Häcker, Frank G. J. Cobelens et al. · 2022 · medRxiv
  96. Screening for Tuberculosis Infection in Risk Groups in the Adult Population of Moscow
    Elena M. Bogorodskaya, L. V. Slogotskaya, L. M. Tuktarova, G. S. Oganezova, N. V. Musatkina, Н. В. Литвинова · 2023 · Tuberculosis and lung diseases
  97. Full-length 16S rDNA sequencing based on Oxford Nanopore Technologies revealed the association between gut-pharyngeal microbiota and tuberculosis in cynomolgus macaques
    Vorthon Sawaswong, Prangwalai Chanchaem, Pavit Klomkliew, Suwatchareeporn Rotcheewaphan, Suthirote Meesawat, Taratorn Kemthong, Mutchamon Kaewparuehaschai, Kirana Noradechanon, Monya Ekatat, Reka Kanitpun et al. · 2024 · Scientific Reports
  98. Advances in understanding immune homeostasis in latent tuberculosis infection
    Liangfei Niu, Hao Wang, Geyang Luo, Jing Zhou, Zhidong Hu, Bo Yan · 2024 · WIREs Mechanisms of Disease
  99. Detailed phenotyping reveals diverse and highly skewed neutrophil subsets in both the blood and airways during active tuberculosis infection
    Shepherd Nhamoyebonde, Mark Chambers, Lerato Ndlovu, Farina Karim, Matilda Mazibuko, Zoey Mhlane, Lindiwe Madziwa, Mahomed‐Yunus S. Moosa, Sashen Moodley, Monjurul Hoque et al. · 2024 · Frontiers in Immunology
  100. 2-Substituted and 1,2-disubstitued benzimidazole derivatives: Synthesis and identification of potential antibacterial agents
    C. G. Arya, Jyothi Kumari, Jai Kishan, Kamini Goswami, Dharmarajan Sriram, Simi Asma Salim, Paramita Pakhira, Siddhardha Busi, Majed Alharbi, Munugala Chandrakanth et al. · 2025 · Journal of Molecular Structure